Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$0.53 - $0.93 $327,911 - $575,391
-618,700 Reduced 10.25%
5,415,715 $3.14 Million
Q4 2023

Feb 13, 2024

BUY
$0.63 - $1.14 $3.41 Million - $6.17 Million
5,414,073 Added 872.76%
6,034,415 $5 Million
Q3 2023

Nov 14, 2023

SELL
$1.12 - $1.88 $3.14 Million - $5.27 Million
-2,804,673 Reduced 81.89%
620,342 $701,000
Q2 2023

Aug 11, 2023

SELL
$1.31 - $2.04 $1.36 Million - $2.13 Million
-1,041,704 Reduced 23.32%
3,425,015 $5.48 Million
Q1 2023

May 12, 2023

BUY
$1.45 - $2.95 $844,775 - $1.72 Million
582,604 Added 15.0%
4,466,719 $6.79 Million
Q4 2022

Feb 13, 2023

SELL
$2.02 - $3.25 $2.52 Million - $4.05 Million
-1,246,300 Reduced 24.29%
3,884,115 $9.32 Million
Q3 2022

Nov 14, 2022

BUY
$1.96 - $3.14 $3.4 Million - $5.45 Million
1,735,800 Added 51.13%
5,130,415 $10.5 Million
Q2 2022

Aug 12, 2022

SELL
$1.3 - $2.64 $1.99 Million - $4.03 Million
-1,528,100 Reduced 31.04%
3,394,615 $6.59 Million
Q1 2022

May 13, 2022

BUY
$2.35 - $3.47 $5.04 Million - $7.44 Million
2,143,000 Added 77.09%
4,922,715 $12.1 Million
Q4 2021

Feb 11, 2022

BUY
$2.92 - $5.74 $2.31 Million - $4.54 Million
790,100 Added 39.71%
2,779,715 $8.95 Million
Q3 2021

Nov 12, 2021

BUY
$4.98 - $6.63 $9.56 Million - $12.7 Million
1,919,600 Added 2741.7%
1,989,615 $10.4 Million
Q2 2021

Aug 13, 2021

SELL
$2.56 - $5.49 $1.33 Million - $2.86 Million
-520,200 Reduced 88.14%
70,015 $384,000
Q1 2021

May 13, 2021

SELL
$2.69 - $5.25 $466,177 - $909,825
-173,300 Reduced 22.7%
590,215 $1.61 Million
Q4 2020

Feb 10, 2021

BUY
$3.17 - $4.49 $1.88 Million - $2.66 Million
592,795 Added 347.23%
763,515 $2.43 Million
Q3 2020

Nov 13, 2020

BUY
$2.98 - $5.2 $4,988 - $8,704
1,674 Added 0.99%
170,720 $683,000
Q2 2020

Aug 13, 2020

SELL
$2.29 - $4.24 $688,596 - $1.27 Million
-300,697 Reduced 64.01%
169,046 $664,000
Q1 2020

May 14, 2020

BUY
$1.92 - $4.39 $169,338 - $387,184
88,197 Added 23.12%
469,743 $1.15 Million
Q4 2019

Feb 13, 2020

BUY
$2.41 - $4.4 $709,263 - $1.29 Million
294,300 Added 337.32%
381,546 $1.55 Million
Q3 2019

Nov 13, 2019

BUY
$2.17 - $3.14 $189,323 - $273,952
87,246 New
87,246 $225,000
Q2 2019

Aug 12, 2019

SELL
$2.53 - $3.04 $84,539 - $101,581
-33,415 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$2.51 - $3.73 $24,597 - $36,554
9,800 Added 41.5%
33,415 $99,000
Q4 2018

Feb 13, 2019

BUY
$1.59 - $2.66 $37,547 - $62,815
23,615 New
23,615 $56,000

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.